Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Am J Surg
    December 2024
  1. MARSHALL TE, Ibrahim R, Lee-Saxton YJ, Tumati A, et al
    Disparities in postoperative adjuvant therapy utilization and factors impacting survival among anaplastic thyroid cancer patients.
    Am J Surg. 2024;238:115944.
    >> Share

  2. COGUA LM, Tupper CJ, Silberstein PT, Coan KE, et al
    Intermediate-sized follicular thyroid cancer surgical trends before and after the 2015 American thyroid association guideline changes.
    Am J Surg. 2024;238:115830.
    >> Share

  3. BARRIO MJ, Pozdeyev N, Raeburn CD, McIntyre RC Jr, et al
    Pre-operative thyroglobulin measurement for thyroid cancer risk of recurrence and response to therapy.
    Am J Surg. 2024;238:115818.
    >> Share

    November 2024
  4. CHAN SJ, Betcher MC, Kuo EJ, McManus CM, et al
    Trends in thyroid function following radiofrequency ablation of benign, nonfunctioning thyroid nodules: A single institution review.
    Am J Surg. 2024;237:115793.
    >> Share

    October 2024
  5. ROSSI L, De Palma A, Ambrosini CE, Fregoli L, et al
    Histologic parameters driving completion thyroidectomy for papillary thyroid carcinoma in a high-volume institution: A retrospective observational study.
    Am J Surg. 2024;239:116016.
    >> Share

    August 2024
  6. SU MW, Beck TN, Knepprath J, Romero-Velez G, et al
    Primary thyroid lymphoma: A multi-center retrospective review.
    Am J Surg. 2024;237:115927.
    >> Share

  7. MONREAL A, Eze AN, Kazaure HS
    Presentation and management of medullary thyroid cancer by sex and race/ethnicity in the United States-A state of disunion.
    Am J Surg. 2024;234:17-18.
    >> Share

  8. GILLIS A, Zmijewski P, Mcleod MC, Lindeman B, et al
    Racial implications of time to surgery in disparities in thyroid cancer survival.
    Am J Surg. 2024;234:85-91.
    >> Share

  9. KALVA S, Ginzberg SP, Passman JE, Soegaard Ballester JM, et al
    Sex differences and racial/ethnic disparities in the presentation and treatment of medullary thyroid cancer.
    Am J Surg. 2024;234:19-25.
    >> Share

    July 2024
  10. BROEKHUIS JM, Gartland RM
    More than meets the size: Evaluating guideline impact on extent of surgery for follicular thyroid carcinoma.
    Am J Surg. 2024 Jul 26:115863. doi: 10.1016/j.amjsurg.2024.115863.
    >> Share

  11. ABRAHAM PJ, Wu C, Wang R, Herring B, et al
    The overtreatment of papillary thyroid microcarcinoma in the community.
    Am J Surg. 2024;233:132-135.
    >> Share

  12. BECK TN, Romero-Velez G, Noureldine SI, Plitt G, et al
    Bilateral exploration in primary hyperparathyroidism: Double adenoma distribution and biochemical patterns over two decades.
    Am J Surg. 2024;233:61-64.
    >> Share

    June 2024
  13. LI R, Luo Q, Gutierrez ID
    Asian Americans have higher 30-day surgical complications after esophagectomy: A propensity-score matched study from ACS-NSQIP database.
    Am J Surg. 2024;232:75-80.
    >> Share

    April 2024
  14. NABATA KJ, Lim R, Leong R, Wiseman SM, et al
    To infinity and beyond: A historical bibliometric analysis of medullary thyroid carcinoma.
    Am J Surg. 2024 Apr 15:S0002-9610(24)00199-5. doi: 10.1016/j.amjsurg.2024.
    >> Share

    March 2024
  15. LEONG D, Leslie C, Laurie B, Hou L, et al
    Tumour size predicts risk of recurrence in tall cell subtype papillary thyroid carcinoma.
    Am J Surg. 2024 Mar 26:S0002-9610(24)00184-3. doi: 10.1016/j.amjsurg.2024.
    >> Share

  16. INNES AM, van Galen P
    Insights from the hereditary endocrine clinic.
    Am J Surg. 2024;229:203-204.
    >> Share

  17. HERRERA M, Hussein MH, Persons E, Alias MR, et al
    Survival benefits of extensive surgery in patients with papillary thyroid microcarcinoma.
    Am J Surg. 2024;229:99-105.
    >> Share

  18. TRAN A, Weigel RJ, Beck AC
    ATA risk stratification in papillary thyroid microcarcinoma has low positive predictive value when identifying recurrence.
    Am J Surg. 2024;229:106-110.
    >> Share

    February 2024
  19. SMITH ER, Frye CC, Pandian TK, Gillanders WE, et al
    Molecular characteristics of isthmus papillary thyroid cancers: Supporting evidence for unfavorable clinical behavior.
    Am J Surg. 2024;228:146-150.
    >> Share

  20. MONTGOMERY KB, Fazendin JM, Chen H, Broman KK, et al
    Contemporary trends in extent of surgery for differentiated thyroid cancer with extrathyroidal extension.
    Am J Surg. 2024;228:173-179.
    >> Share

    August 2023
  21. KUO LE, Suh I
    Can we improve preoperative staging for thyroid cancer?
    Am J Surg. 2023;226:170.
    >> Share

  22. K SAH R, Mayilvaganan S
    "Primary hyperparathyroidism after radioactive iodine therapy. Is it a distinct clinical entity?".
    Am J Surg. 2023;226:296.
    >> Share

  23. SOEGAARD BALLESTER JM, Finn CB, Ginzberg SP, Kelz RR, et al
    Thyroid cancer pathologic upstaging: Frequency and related factors.
    Am J Surg. 2023;226:171-175.
    >> Share

    July 2023
  24. SANDILOS G, Lou J, Butchy MV, Gaughan JP, et al
    Features of mixed medullary thyroid tumors: An NCDB analysis of clinicopathologic characteristics and survival.
    Am J Surg. 2023;226:53-58.
    >> Share

    June 2023
  25. WATANABE A, Wiseman SM
    Quality indicators for thyroid cancer care: What should surgeons know?
    Am J Surg. 2023;225:1108-1110.
    >> Share

  26. GOODSELL K, Ermer J, Amjad W, Swisher-McClure S, et al
    External beam radiotherapy for thyroid cancer: Patients, complications, and survival.
    Am J Surg. 2023;225:994-999.
    >> Share

    May 2023
  27. MASHAT A, Hilzenrat R, Masoudi H, Walker B, et al
    The influence of papillary features on the risk of malignancy in thyroid nodules diagnosed as atypia of undetermined significance or follicular lesion of undetermined significance.
    Am J Surg. 2023;225:857-860.
    >> Share

    March 2023
  28. ZHAO HH, Pickney C, Sarode AL, Kim-Mackow A, et al
    Varying impact of patient age on the rising rate of pediatric thyroid cancer: Analysis of NCDB database (2004-2017).
    Am J Surg. 2023;225:532-536.
    >> Share

    February 2023
  29. LUFF MK, Kim J, Tseng CH, Livhits MJ, et al
    Racial/ethnic disparities in thyroid cancer in California, 1999-2017.
    Am J Surg. 2023;225:298-303.
    >> Share

    January 2023
  30. BOBANGA I, Jin J, Wilhelm S, Sarode A, et al
    Primary hyperparathyroidism after radioactive iodine therapy: Is it a distinct clinical entity?
    Am J Surg. 2023;225:180-183.
    >> Share

    December 2022
  31. SWANSON J, Littau M, Tonelli C, Cohn T, et al
    A matched cohort comparison of endoscopic resection, chemoradiation and esophagectomy in the treatment of early-stage esophageal squamous cell carcinoma.
    Am J Surg. 2022 Dec 2:S0002-9610(22)00782-6. doi: 10.1016/j.amjsurg.2022.
    >> Share

    November 2022
  32. KITAJIMA T, Okugawa Y, Shimura T, Yamashita S, et al
    Combined assessment of muscle quality and quantity predicts oncological outcome in patients with esophageal cancer.
    Am J Surg. 2022 Nov 29:S0002-9610(22)00771-1. doi: 10.1016/j.amjsurg.2022.
    >> Share

    October 2022
  33. HSIAO V, Hanlon BM, Robbins SE, Connor NP, et al
    Discovering domains important to health-related quality of life in differentiated thyroid cancer.
    Am J Surg. 2022;224:1176-1178.
    >> Share

    September 2022
  34. FUNG MMH, Lang BH
    A prospective study evaluating the use of low-dose intravenous sedation and analgesia during radiofrequency ablation of symptomatic, benign thyroid nodules.
    Am J Surg. 2022;224:928-931.
    >> Share

    August 2022
  35. HARVEY A
    Using what we already have: Optimizing information from ultrasound and fine needle aspiration biopsy for decision making in thyroid nodular disease.
    Am J Surg. 2022;224:652.
    >> Share

  36. PAJAK C, Cadili L, Nabata K, Wiseman SM, et al
    (68)Ga-DOTATATE-PET shows promise for diagnosis of recurrent or persistent medullary thyroid cancer: A systematic review.
    Am J Surg. 2022;224:670-675.
    >> Share

  37. DICKEY MV, Nguyen A, Wiseman SM
    Cancer risk estimation using American College of Radiology Thyroid Imaging Reporting and Data System for cytologically indeterminate thyroid nodules.
    Am J Surg. 2022;224:653-656.
    >> Share

  38. SUJKA J, DuCoin CG
    Dr. Velanovich's contributions to understanding Barrett's Esophagus and its treatment.
    Am J Surg. 2022;224:821-822.
    >> Share

    July 2022
  39. STEINL GK, Stewart LA, McManus C, Lee JA, et al
    Ethanol ablation for the treatment of benign thyroid nodules.
    Am J Surg. 2022;224.
    >> Share

  40. SUTTON W, Crepeau PK, Canner JK, Karzai S, et al
    Impact of the 2015 American thyroid association guidelines on treatment in older adults with low-risk, differentiated thyroid cancer.
    Am J Surg. 2022;224.
    >> Share

    April 2022
  41. TAKEDA E, Kimura J, Okabayashi T, Sui K, et al
    Clinicopathological features and surgical outcomes of pancreatic metastasis from thyroid cancer.
    Am J Surg. 2022 Apr 12. pii: S0002-9610(22)00237.
    >> Share

  42. ZMIJEWSKI P, Kuo LE
    Can less Be more in the treatment of cN1a papillary thyroid microcarcinoma?
    Am J Surg. 2022;223:633-634.
    >> Share

  43. RAMONELL KM, Yip L
    The impact of race and ethnicity on thyroid nodules, malignancy risk, and surgical management.
    Am J Surg. 2022;223:615-616.
    >> Share

  44. ZHENG H, Lai V, Lu J, Kang JK, et al
    Comparing the rate and extent of malignancy in surgically excised thyroid nodules across race and ethnicity.
    Am J Surg. 2022;223:617-623.
    >> Share

  45. RAMONELL KM, Rentas C, Buczek E, Porterfield J Jr, et al
    Mediastinal parathyroidectomy: Utilization of a multidisciplinary, robotic-assisted transthoracic approach in challenging cases.
    Am J Surg. 2022;223:681-685.
    >> Share

  46. MATSON J, Lwin TM, Bouvet M
    Rapid intraoperative perfusion assessment of parathyroid adenomas with ICG using a wide-field portable hand-held fluorescence imaging system.
    Am J Surg. 2022;223:686-693.
    >> Share

    February 2022
  47. REILLY J, Faridmoayer E, Lapkus M, Pastewski J, et al
    Vascular invasion predicts advanced tumor characteristics in papillary thyroid carcinoma.
    Am J Surg. 2022 Feb 10. pii: S0002-9610(22)00091.
    >> Share

  48. SHALABY M, Hadedeya D, Toraih EA, Razavi MA, et al
    Predictive factors of radioiodine therapy failure in Graves' Disease: A meta-analysis.
    Am J Surg. 2022;223:287-296.
    >> Share

    January 2022
  49. KELLEY S, Beck AC, Weigel RJ, Howe JR, et al
    Influence of endocrine multidisciplinary tumor board on patient management and treatment decision making.
    Am J Surg. 2022;223:76-80.
    >> Share

    December 2021
  50. REILLY J, Faridmoayer E, Lapkus M, Pastewski J, et al
    Vascular invasion predicts advanced tumor characteristics in papillary thyroid carcinoma.
    Am J Surg. 2021 Dec 9. pii: S0002-9610(21)00724.
    >> Share

    October 2021
  51. ARYANPOUR Z, Asban A, Boyd C, Herring B, et al
    A single institution experience with papillary thyroid cancer: Are outcomes better at comprehensive cancer centers?
    Am J Surg. 2021;222:802-805.
    >> Share

    September 2021
  52. RAMONELL KM, Fazendin J
    The complex and heterogeneous entity of double adenomas in primary hyperparathyroidism.
    Am J Surg. 2021;222:481-482.
    >> Share

  53. GOODSELL KE, Ermer JP, Zaheer S, Kelz RR, et al
    Double adenoma as a cause of primary hyperparathyroidism: Asymmetric hyperplasia or a distinct pathologic entity?
    Am J Surg. 2021;222:483-489.
    >> Share

  54. LIMBERG J, Stefanova D, Thiesmeyer JW, Ullmann TM, et al
    Association of medicaid expansion of the Affordable Care Act with the stage at diagnosis and treatment of papillary thyroid cancer: A difference-in-differences analysis.
    Am J Surg. 2021;222:562-569.
    >> Share

    August 2021
  55. BACK K, Lee J, Choe JH, Kim JH, et al
    Total thyroidectomy can be overtreatment in cN1a papillary thyroid carcinoma patients whose tumor is smaller than 1 cm.
    Am J Surg. 2021 Aug 12. pii: S0002-9610(21)00474.
    >> Share

  56. SINCLAIR CF, Tellez MJ, Pelaez-Cruz R, Diaz-Baamonde A, et al
    Continuous neuromonitoring during radiofrequency ablation of benign thyroid nodules provides objective evidence of laryngeal nerve safety.
    Am J Surg. 2021;222:354-360.
    >> Share

    July 2021
  57. MCDOW AD, Roman BR, Saucke MC, Jensen CB, et al
    Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer.
    Am J Surg. 2021;222:111-118.
    >> Share

  58. MUSAVI LS, Fadavi D, He W, Sacks JM, et al
    Impact of payer status and hospital volume on outcomes after head and neck oncologic reconstruction.
    Am J Surg. 2021;222:173-178.
    >> Share

    June 2021
  59. SCHWEITZER CL, Wiseman SM
    Adoption of intraoperative nerve monitoring for thyroidectomy: Supported by real-world NSQIP data.
    Am J Surg. 2021;221:1285-1290.
    >> Share

  60. WISEMAN SM, Saleh N, Tootooni A, Eshraghi P, et al
    Parathyroid identification during thyroid and parathyroid operations: A pilot study evaluating a novel low cost autofluorescence based device.
    Am J Surg. 2021;221:1150-1158.
    >> Share

    May 2021
  61. ESCE AR, Redemann JP, Sanchez AC, Olson GT, et al
    Predicting nodal metastases in papillary thyroid carcinoma using artificial intelligence.
    Am J Surg. 2021 May 13. pii: S0002-9610(21)00281.
    >> Share

  62. NYLEN C, Eriksson FB, Yang A, Aniss A, et al
    Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer.
    Am J Surg. 2021;221:886-892.
    >> Share

    April 2021
  63. WILSON M, Patel A, Goldner W, Baker J, et al
    Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
    Am J Surg. 2021;221:804-808.
    >> Share

    March 2021
  64. BORTZ MD, Khokar A, Winchester DJ, Moo-Young TA, et al
    Radioactive iodine-125 seed localization as an aid in reoperative neck surgery.
    Am J Surg. 2021;221:534-537.
    >> Share

  65. TAKEDA FR, Kodama Pertille Ramos MF, Pereira MA, Muniz RR, et al
    Predictive factors of recurrence in adenocarcinoma of the esophagogastric junction in the multimodal era.
    Am J Surg. 2021;221:631-636.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016